ArticleFrontiers in cardiovascular medicine2026

Exploratory observational study with Two-year outcomes of early in-hospital evolocumab in acute coronary syndrome patients undergoing coronary artery bypass grafting.

Giuseppe Nasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.